Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial. (nature.com)

Authors: Valero V … Meric-Bernstam F Journal: Nature Communications Published: 2026-08-22 DOI: https://doi.org/10.1038/s41467-026-76662-6